Takeda Philippines bags “Investor in People” award

Takeda Healthcare Philippines Inc (THPI) was awarded the “Investors in People” silver accreditation, a recognition which highlights the company’s commitment to high performance through effective people management.

Investors in People is an international standard for people management, defining what it takes to lead, support and manage people effectively to achieve sustainable results. The Investors in People framework process reflects and takes into consideration workplace trends, essential skills and effective structures required to outperform in any industry. Investors in People allows organizations to benchmark against the best in the business on an international scale.

Gabriel Georgy, President & General Manager of Takeda Healthcare Philippines said, “We can say we have successfully laid the foundations to become a Best Employer in the Philippines. Our aim is to continue to strive for excellence in the work place while we help our people reach their full potential and achieve success in their careers.”

Paul Devoy, Head of Investors in People said, “Investors in People Philippines, and I would like to take this opportunity to congratulate Takeda Philippines. Our accreditation is the sign of a great employer, an outperforming work place and a clear commitment to success.”

Takeda Healthcare Philippines currently employs around 250 people, and has been operating since 2015. Takeda Healthcare Philippines also recently received certification from the Top Employer Institute.

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit https://www.takeda.com/newsroom.